Select Page

News

Hot off the presses: PRF’s 2021 Annual Newsletter is here!

Hot off the presses: PRF’s 2021 Annual Newsletter is here!

Check out our newsletter to read about FDA approval for the first-ever treatment for Progeria, learn how the research we fund has made remarkable progress toward the cure through genetic and RNA therapies, and get the scoop on all the exciting milestones we’re celebrating right now.

read more
Another year of top Charity Navigator ratings!

Another year of top Charity Navigator ratings!

We’re thrilled to share that PRF has been awarded the highest 4-star Charity Navigator rating for our 8th straight year! CharityNavigator is the top evaluator of U.S.-based nonprofits, and this coveted 4-star rating is only awarded to 6% of the nonprofits evaluated....

read more
Exciting breakthroughs in RNA Therapeutics for Progeria!

Exciting breakthroughs in RNA Therapeutics for Progeria!

We’re thrilled to share the results from two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research. Both studies were co-funded by The Progeria Research Foundation (PRF) and co-authored by PRF’s Medical Director, Dr. Leslie Gordon.

read more
Kicking off the New Year with exciting research news!

Kicking off the New Year with exciting research news!

In January, the science journal Nature published breakthrough results demonstrating that genetic editing in a mouse model of Progeria corrected the mutation that causes Progeria in many cells, improved several key disease symptoms and dramatically increased lifespan in the mice.

read more